Myeloma (cancer of plasma cells) is a malignant blood disease that occurs due to a malfunction of the plasma cells in the bone marrow. Plasma cells are present both in the blood and in the bone marrow. With this type of cancer, no single tumor is formed, cancer cells are present in the bone marrow all over the place. With myeloma, round foci of different size can be formed in the bones, displacing healthy tissue and increasing the probability of bone fracture. The disease can be the cause of brittle bones (osteoporosis).
If the disease has not spread, the calcium content in the blood is normal, there are no changes in bone tissue, and the kidney function is not broken, the treatment can be postponed and simply monitor the condition. In this case, it is asymptomatic myeloma. The patient is recommended to undergo regular examinations. Prematurely begun treatment is accompanied by numerous side effects and does not prolong the life of the patient.
It is recommended to start treatment only when the patient suffers from obvious symptoms of the disease or when the examination reveals functional disorders in the body, for example, changes in the bones or kidney dysfunction. Modern methods of treatment provide for a combination of different drugs; the therapy is selected individually, taking into account the age of the patient and possible co-morbidities. Most often for treatment, cortisone is used in high doses in combination with other chemotherapeutic drugs, including the latest antitumor drugs for the treatment of myeloma.
Supportive therapy plays an important role in the treatment of myeloma. To relieve pain in the bones are prescribed strong painkillers, if necessary, radiation therapy is performed. Appointed drugs that strengthen bone tissue. Physical activity plays an important role in strengthening the bones. For the prevention of infections should take drugs that have an antimicrobial effect.